2397 — DNA Chip Research Share Price
0.000.00%
Last trade - 00:00- ¥7bn
- ¥7bn
- ¥490m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10.41 | ||
| Price to Tang. Book | 12.51 | ||
| Price to Free Cashflow | 8,324.77 | ||
| Price to Sales | 7.66 | ||
| EV to EBITDA | 1,216.37 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -6.15% | ||
| Return on Equity | -5.84% | ||
| Operating Margin | -4.83% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 361.71 | 324.5 | 427.94 | 327.54 | 490.46 | n/a | n/a | 6.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DNA Chip Research Inc. is primarily engaged in DNA chip-related analysis and next-generation sequence related technology research business, and diagnostic business which is engaged in the sales of medical-related equipment centered on EGFR-NGS Check. The Contract Research segment is engaged in the microarray, next-generation sequencing experiment analysis to universities and research institutes, pharmaceutical and food companies. The Diagnostic segemnt utilizes genetic analysis technology to disseminate tests corresponding to social needs on personalized medicine and undiseased society. The main menu of the diagnostic business is EGFR-NGS Check. The Research and Development segment includes research on cancer diagnosis technology using next generation sequencer, as well as the development of RNA check.
Directors
- Ryo Matoba PRE (48)
- Keiji Sato OTH (43)
- Kunio Yamada DRC (68)
- Tokio Katayama IND (76)
- Shoko Kawamoto IND (56)
- Takaaki Sato IND (61)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 1st, 1999
- Public Since
- March 18th, 2004
- No. of Shareholders
- 4,397
- No. of Employees
- 37
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 6,760,536
- Address
- 5F, Suzue Baydium, 1-15-1, Kaigan, KAWASAKI-SHI, 211-0004
- Web
- https://www.dna-chip.co.jp/
- Phone
- +81 357771700
- Auditors
- Seiyo Audit Corporation
Upcoming Events for 2397
Similar to 2397
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
What is the DNA Chip Research share price?
As of Today at 20:16 UTC, shares in DNA Chip Research are trading at ¥1,091. This share price information is delayed by 15 minutes.
How has the DNA Chip Research share price performed this year?
Shares in DNA Chip Research last closed at ¥1,091 and the price had moved by +4.3% over the past 365 days. In terms of relative price strength the DNA Chip Research share price has outperformed the Nikkei 225 Index by +9.92% over the past year.
What are the analyst and broker recommendations for DNA Chip Research?
There is no consensus recommendation for this security.
Find out moreWhat is the DNA Chip Research dividend yield?
DNA Chip Research does not currently pay a dividend.
Does DNA Chip Research pay a dividend?
DNA Chip Research does not currently pay a dividend.
When does DNA Chip Research next pay dividends?
DNA Chip Research does not currently pay a dividend.
How do I buy DNA Chip Research shares?
To buy shares in DNA Chip Research you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of DNA Chip Research?
As of the previous close price of ¥1,091, shares in DNA Chip Research had a market capitalisation of ¥7bn.
Where are DNA Chip Research shares listed?
Here are the trading details for DNA Chip Research:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 2397
What kind of share is DNA Chip Research?
Based on an overall assessment of its quality, value and momentum DNA Chip Research is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a DNA Chip Research share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the DNA Chip Research share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DNA Chip Research. Over the past six months, its share price has outperformed the Nikkei 225 Index by +67.56%.
As of the last closing price of ¥1,091, shares in DNA Chip Research were trading +29.67% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the DNA Chip Research PE Ratio?
The DNA Chip Research PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥1,091.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of DNA Chip Research?
DNA Chip Research's management team is headed by:
- Ryo Matoba - PRE
- Keiji Sato - OTH
- Kunio Yamada - DRC
- Tokio Katayama - IND
- Shoko Kawamoto - IND
- Takaaki Sato - IND